🏢
AbbVie
ABBV · sp500
$227.73
+1.32% today
$217.72
Open
$228.40
High
$224.32
Low
$381.10B
Market cap
⏱️ Updated: 20:57 · ⚠️ ~15 min delay
🏢 About AbbVie
AbbVie is a global biopharmaceutical company that spun off from Abbott Laboratories in 2013. Its blockbuster drug Humira held the title of world's best-selling medicine for many years before patent expiry. AbbVie has built a diversified portfolio through the acquisition of Allergan, adding Botox and other aesthetics products, as well as developing new immunology and oncology drugs such as Skyrizi and Rinvoq.
📈 30-day price history
| Date | Close | Volume |
|---|---|---|
| 12 Jun | $224.77 | 4,488,049 |
| 11 Jun | $224.95 | 4,133,222 |
| 10 Jun | $225.42 | 4,060,335 |
| 09 Jun | $223.07 | 4,878,220 |
| 08 Jun | $227.23 | 4,818,022 |
| 30 May | $217.72 | – |
| 25 May | $215.70 | 3,974,116 |
| 14 May | $212.18 | – |
| 12 May | $202.78 | – |
| 09 May | $201.55 | 3,341,523 |
| 08 May | $202.71 | – |
| 07 May | $205.03 | – |
| 29 Apr | $197.69 | 4,872,069 |